These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16535920)

  • 1. New rheumatoid arthritis treatment has potential to reduce payer's costs.
    Morrow T
    Manag Care; 2006 Feb; 15(2):58-9. PubMed ID: 16535920
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic pains of rheumatoid arthritis.
    Smith MD; McGhan WF
    Bus Health; 1997 Feb; 15(2):55-6, 58. PubMed ID: 10164782
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis.
    Inotai A; Mészáros A
    Int J Technol Assess Health Care; 2009 Apr; 25(2):190-5. PubMed ID: 19366498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biggest increases in specialty drug costs seen in rheumatologic, cancer, and hemophilia agents.
    Manag Care; 2005 Feb; 14(2):68. PubMed ID: 15782849
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospital cost containment: a payer's prognosis.
    Bailey WO
    Empl Benefits J; 1983 Sep; 8(3):19-21, 29. PubMed ID: 10261528
    [No Abstract]   [Full Text] [Related]  

  • 6. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
    Renato GM
    Ann N Y Acad Sci; 2009 Sep; 1173():729-35. PubMed ID: 19758222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modest proposal.
    Lipsky PE
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):343. PubMed ID: 16932714
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab for the treatment of rheumatoid arthritis.
    Schuna AA
    Pharmacotherapy; 2007 Dec; 27(12):1702-10. PubMed ID: 18041890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of rheumatoid arthritis and access to treatment: determinants of access.
    Lundqvist J; Kastäng F; Kobelt G; Jönsson B
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S87-93. PubMed ID: 18157560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient access to rheumatoid arthritis treatments.
    Jönsson B
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S35-8. PubMed ID: 18157679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of rheumatoid arthritis and access to treatment: health burden and costs.
    Lundkvist J; Kastäng F; Kobelt G
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S49-60. PubMed ID: 18157732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early rheumatoid arthritis.
    Machold KP; Nell V; Stamm T; Aletaha D; Smolen JS
    Curr Opin Rheumatol; 2006 May; 18(3):282-8. PubMed ID: 16582693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back to the future: the managed care approach to rheumatoid arthritis.
    Sidorov J
    Manag Care Interface; 2007 Jul; 20(7):28-30. PubMed ID: 17849731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
    Yukawa N; Mimori T
    Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical models of arthritic disease in non-human primates.
    Vierboom MP; Jonker M; Tak PP; 't Hart BA
    Drug Discov Today; 2007 Apr; 12(7-8):327-35. PubMed ID: 17395093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 17. Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
    Bansard C; Lequerré T; Daveau M; Boyer O; Tron F; Salier JP; Vittecoq O; Le-Loët X
    Rheumatology (Oxford); 2009 Sep; 48(9):1021-8. PubMed ID: 19483089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of B-lymphocytes in pathogenesis of rheumatoid arthritis].
    Novak S
    Reumatizam; 2007; 54(2):71. PubMed ID: 18351145
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in economic consequences of rheumatoid arthritis over two subsequent years.
    Verstappen SM; Jacobs JW; Kruize AA; Ehrlich JC; van Albada-Kuipers GA; Verkleij H; Buskens E; Bijlsma JW
    Rheumatology (Oxford); 2007 Jun; 46(6):968-74. PubMed ID: 17337750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis in a military aviator.
    Moszyk DJ; Sulit DJ
    Aviat Space Environ Med; 2007 Jan; 78(1):63-6. PubMed ID: 17225486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.